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Protocol
AbstrACt
Introduction 1.2 million people in the UK have chronic 
obstructive pulmonary disease (COPD) that causes 
breathlessness, difficulty with daily activities, infections 
and hospitalisation. Pulmonary rehabilitation (PR), a 
programme of supervised exercise and education, is 
recommended for patients with COPD. However, only 
1 in 10 of those who need it receive PR. Also, the UK 
National COPD Audit Programme concluded that the 
COPD treatment might not be accessible to people 
with disabilities. This paper applies an Inclusive Design 
approach to community-based PR service provisions. 
It aims to inform improvements to the PR service by 
identifying barriers to the uptake of PR in the COPD care 
journey in relation to patients’ capabilities that can affect 
their access to PR.
Methods and analysis The protocol includes four steps. 
Step 1 will involve interviews with healthcare professionals 
and patients to gather insight into their experiences and 
produce a hierarchical task analysis of the COPD care 
journeys. Step 2 will estimate the service exclusion: the 
demand of every task on patients’ capabilities will be 
rated by predefined scales, and the proportion of the 
population excluded from the service will be estimated by 
an exclusion calculator. Step 3 will identify the challenges 
of the PR service; a framework analysis will guide the data 
analysis of the interviews and care journey. Step 4 will 
propose recommendations to help patients manage their 
COPD care informed by the challenges identified in step 3 
and refine recommendations through interviews and focus 
groups.
Ethics and dissemination The Cambridge Central 
Research Ethics Committee gave the study protocol a 
positive ethical opinion (17/EE/0136). Study results will be 
disseminated through peer-reviewed journals, conferences 
and the British Lung Foundation networks. They will 
also be fed into a Research for Patient Benefit project on 
increasing the referral and uptake of PR.
IntroduCtIon  
underutilisation of pulmonary rehabilitation (Pr)
Chronic obstructive pulmonary disease 
(COPD) is a progressive lung disease in 
which people experience breathlessness, 
exercise incapacity and vulnerability to 
exacerbations, frequently requiring hospi-
talisation. According to the WHO estimates, 
65 million people have moderate to severe 
COPD.1 Globally, it is estimated that about 
3 million deaths were caused by the disease 
in 2015 (ie, 5% of all deaths globally in that 
year). Approximately 1.2 million people live 
with COPD2 in the UK and a large propor-
tion of them are older people. This condition 
costs the UK National Health Service (NHS), 
a publicly funded national healthcare system, 
£800 million per year, mostly relating to 
hospital admissions.3 The UK National Insti-
tute for Health and Care Excellence recom-
mends that PR, providing supervised exercise 
and education, can be offered to patients 
functionally disabled by COPD.4 PR improves 
symptoms, exercise capacity and quality 
of life5 and leads to fewer repeating exac-
erbations requiring admission or hospital 
strengths and limitations of this study
 ► This protocol uses a novel Inclusive Design method 
and tools to identify and quantify health service ex-
clusion and make recommendations for improving 
the accessibility of community-based pulmonary 
rehabilitation (PR) services.
 ► Representative healthcare professionals and pa-
tients were involved in all aspects of the protocol 
development to ensure a systematic representation 
of the real care processes and identification of real 
issues.
 ► While there are many factors that influence the up-
take of PR, this study focuses on patients’ individual 
capabilities in relation to accessing the service.
 ► Although PR forms the basis of this protocol, the 
focus could be modified for application to other 
healthcare services, particularly for communi-
ty-based treatments of other long-term conditions.
 ► The Inclusive Design methods and tools consider 
physical and cognitive exclusion, while other types 
of exclusion, for instance social or psychological, are 
not included in the analysis.
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attendance.6 7 It plays an important role in fostering 
self-management skills.8 
The National COPD Audit Programme9 estimated that 
the number of patients with COPD eligible for PR in 
England and Wales in 2013/2014 was 446 000; however, 
despite evidence-based guidelines,10 11 there were only 
68 000 referrals (15% of normative need) during that 
period, and only 69% of those attended an initial assess-
ment (10% of normative need).9 Referral and attendance 
figures in the East of England (EoE) are not available, 
but we have no reason to believe that the local figures 
are significantly different from the national figures. 
The audit highlighted the need to improve referral and 
uptake rates. It recommended that PR referral pathways, 
healthcare professional (HCP) training, information 
for patients and referrers and barriers to patient access 
should be reviewed. The audit also demonstrated that 
the availability of COPD treatment for the full range of 
severity of disability is not inclusive.12
the evidence gap
Several studies have been carried out to identify barriers 
that prevent access to PR.13–21 Most of these barriers have 
been identified as relating to the context or environ-
ment, people’s knowledge and patients’ and clinicians’ 
beliefs.22 For example, referral to PR can be influenced by 
a difficult referral process and a lack of knowledge about 
PR, while uptake can be affected by the lack of transport 
and geographic distance to a programme, as well as the 
quality of the HCP’s conversation with patients about 
PR. There is little understanding of how patients’ own 
physical and cognitive capabilities (including mobility, 
dexterity, reach and stretch, vision, hearing, thinking 
and communication) relate to their ability to access PR 
and affect implementation of the care service. People’s 
personal capability to access a healthcare service is a 
prerequisite for them to use it. Moreover, patients with 
COPD are likely to have limited mobility. Hence, it is 
very important to consider patients’ capabilities in order 
to improve access to PR services. Insight into the capa-
bility demand within the COPD care pathway (ie, the 
demands that the care pathway makes on people’s capa-
bility) would help care providers to better understand 
the needs of patients and to support their engagement in 
PR. Therefore, this research will focus on understanding 
people’s capability-related needs while accessing PR 
within the community.
study aim
The aim of the study is to provide recommendations for 
how primary care PR services in the EoE could improve 
and increase patients’ access to PR services. An Inclu-
sive Design approach will be used to estimate the system 
demands on patients with COPD and evaluate PR services’ 
exclusion, identifying ways in which the care pathway 
excludes patients and ways in which the care pathway 
design can be modified to provide inclusive access to PR 
for as many eligible patients as possible.
The research question is: how can Inclusive Design be 
used to improve patients’ access to PR services within the 
community?
MEthods And AnAlysIs
overview of methods
Three central concepts will be characterised, namely, (A) 
Inclusive Design; (B) people’s capabilities; and (C) the 
care pathway/journey. In addition, the link between Inclu-
sive Design and patients’ access to PR will be considered.
Inclusive Design
Inclusive Design can be defined as: (1) ‘the design of 
mainstream products and/or services that are accessible 
to, and usable by, people with the widest range of abilities 
within the widest range of situations without the need for 
special adaptation or design’,23 and (2) ensuring that the 
demand made on an individual in a given environment 
does not exceed their capability to respond.24 In this 
study, Inclusive Design refers to the latter definition.
The Inclusive Design approach is a rigorous user-cen-
tred approach, where the fundamental premise is that 
accessible and usable products or services can only be 
developed or implemented by first knowing the intended 
users.25 By understanding the user’s capability demand in 
a healthcare context, it is easier to understand their capa-
bility-related needs for care and enhance the implemen-
tation of the healthcare services. 
People’s capabilities
Capabilities in this context refer to people’s abilities to 
access health services. There are mainly two factors that 
cause a change in people’s capability: one is an age-re-
lated change in capability, and the other is a change in 
condition-related capability. Regarding patients with 
COPD, a large proportion are older people2 and the 
condition of COPD, as well as the ageing process, may 
significantly impact their capability. People with COPD 
may be more frail, weaker and have reduced exercise 
and activity levels.26 Moreover, they may be burdened by 
high levels of anxiety and depression as well as recognised 
cognitive impairment, particularly at the time of exac-
erbation.27 Many patients have significant differences 
in their functioning compared with peers. While some 
of these manifestations relate solely to the presence of 
COPD, multimorbidity is common and clearly could 
further impact on patients’ capabilities.
Care pathway/journey
‘Care pathway’ or ‘care journey’ are both terms used to 
describe the process of healthcare service delivery. Care 
pathways are more generic and described from an organ-
isational perspective. A pathway may take the form of an 
integrated management plan that provides a sequence 
and timing of actions necessary to achieve a standard 
care process and optimal efficiency for clinicians.28 
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For example, the main stages in the NHS primary care 
pathway of COPD rehabilitation are shown in figure 1.
A patient’s care journey refers to the process that he or 
she goes through in order to receive the care. As shown 
in figure 2, we define the care journey as a series of tasks. 
For example, the first stage in figure 1, that is, COPD 
diagnosis, can be further broken down into four tasks: 
(1) make an appointment with a general practitioner 
(GP); (2) go to the GP practice; (3) have a GP consulta-
tion; and (4) obtain a diagnosis. The detailed care jour-
neys that patients experience in accessing the PR service 
would be more easily identified in the context of a deeper 
understanding of COPD services.
The connection between Inclusive Design and patients’ access to 
PR
Any service makes demands on patients, and patients 
have to have sufficient capabilities in order to respond to 
these demands and access the service (figure 3).29 If the 
demands of accessing the PR service exceed the capabil-
ities of the patients, then exclusion or difficulty in using 
the service will arise. Taking the task ‘go to the GP prac-
tice’ as an example, if the home of a patient with COPD 
is relatively far from the GP surgery and the patient’s 
mobility is limited, then he or she may not be able to get 
to the GP practice. In this case, this patient is excluded 
from the PR service as he or she cannot even see the 
doctor. With a better understanding of the tasks in the 
patient care journey, we are able to estimate the service’s 
system demands on patients’ capabilities and analyse the 
extent of system inclusion.
study procedures
As illustrated in figure 4, the research is divided into four 
steps: semistructured interviews will be used in step 1 
(mapping pathway); step 2 (estimate exclusion) and step 
3 (identify challenges) are mainly data analysis, and inter-
views and focus groups will be used in step 4 (propose 
recommendation).
Step 1: mapping pathway
Interviews with HCPs
We will conduct interviews with HCPs (including GPs, prac-
tice nurses and physiotherapists) who refer patients to PR, as 
well as PR service managers and healthcare commissioners 
(see section sampling and recruitment for details).
The interviews with HCPs will gather insight into their 
experiences and perception of the COPD care pathway. 
The main stage of the NHS primary care pathway (see 
figure 1) will be presented to HCPs, and the detailed 
primary care clinicians’ pathways for PR will be identified 
based on the interview data. This understanding of the 
care pathway from the clinicians’ perspective will be used 
to help map patients’ care journeys. Specifically, we will 
focus on the pathway from diagnosis to PR programme 
attendance, while recognising the number of possible 
different routes to PR referral. Patients’ ability to do 
exercises and take part in PR once they have accessed the 
service is not the focus of this research. The questions are 
shown in online supplementary appendix 1.
Interviews with patients
Three categories of patients with COPD will be interviewed: 
patients who have accepted a PR offer, patients who have 
declined a PR offer and patients who have never been 
referred to PR (see section sampling and recruitment for 
details).
The interviews with patients with COPD will capture 
the detailed COPD care journey from patients’ perspec-
tives, gather insight into patients’ experiences of PR and 
their care needs and assess the capabilities of patients 
with COPD. The questions are shown in online supple-
mentary appendices 2 and 3.
Data analysis: (1) transcriptions and field notes will 
be managed and analysed using NVivo software. (2) 
The detailed care journeys that patients go through to 
receive COPD treatment and the detailed care pathway 
that HCPs engage in when delivering COPD treatment 
Figure 1 The main stages in the NHS primary care pathway of COPD rehabilitation are: (1) COPD diagnosis, (2) annual 
review, (3) referral for pulmonary rehabilitation, (4) assessment for pulmonary rehabilitation and (5) pulmonary rehabilitation 
programme. COPD, chronic obstructive pulmonary disease; NHS, National Health Service.
Figure 2 Care journeys consist of specific tasks. The 
first stage of the NHS primary care pathway of COPD 
rehabilitation, COPD diagnosis, can be further broken down 
into four tasks: (1) make an appointment with a general 
practitioner (GP); (2) go to the GP practice; (3) have a GP 
consultation; and (4) obtain a diagnosis. COPD, chronic 
obstructive pulmonary disease.
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will be summarised and represented as a hierarchical task 
analysis30 (figure 5). For example, the stage 1 COPD diag-
nosis in figure 1 could be further broken down into the 
following steps: make an appointment with a GP, go to 
the GP Practice, have a GP consultation and obtain diag-
nosis (figure 2). Making an appointment with a GP can 
be done by telephone or computer, could be booked by 
dropping in or could be booked by others. Making an 
appointment by telephone can be further broken down 
into the following steps: make a telephone call, request 
an appointment, agree on details and mark in diary. (3) 
The similarities and differences between the care pathway 
from the HCPs’ perspectives and the care journey from 
the patients’ perspectives will also be explored.
Output: a map of the patients’ care journey will be 
defined. This will be used in step 2 to estimate the reasons 
and levels of exclusion.
Step 2: estimate exclusion 
Estimate how demanding the COPD care journey is for patients
Tasks will be analysed to determine the demands of 
the COPD care journey on patients. Specifically, the 
demand of every task will be rated by predefined scales. 
These scales were constructed based on the questions in 
the Disability Follow-up to the Family Resources Survey, 
which was originally performed to help plan welfare 
support for disabled people.31 The survey of more than 
7000 people included many with respiratory conditions 
Figure 3 Interaction context-Demand and Capabilities (Persad et al29). The example is of a physical product, but this applies 
equally to services. Reproduced from www.inclusivedesigntoolkit.com with permission.
Figure 4 Study design. COPD, chronic obstructive pulmonary disease.
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including COPD. Subsequently, these data have been 
used to assess numerous products and services.31–33 
Examples of assessing hearing, reach and speech 
comprehension demand scales are shown in figure 6. 
Higher demand on peoples’ capabilities causes higher 
scale ratings, and the symbol ‘>’ off scale means it is 
excessive for a mainstream service.
With the predefined scales, the demand on every task 
will be assessed. For example, the task ‘to make a tele-
phone call’ places demands on patients’ sensory capa-
bilities (to hear clearly throughout the call and see the 
number buttons), motor capabilities (to hold the phone 
and press the number buttons) and cognitive capabili-
ties (to remember/know the telephone number to call 
and communicate with the receptionist). The demand 
of this task on patients’ hearing capability is close to the 
scale 8, that is, use telephone without special adapta-
tions for hearing impairment, so the hearing demand is 
rated scale 8 (figure 7). The level of the tasks’ descrip-
tion is matched against the details of predefined scales.
Estimate the number of people excluded from PR on the basis of 
their capabilities
The ‘Exclusion Calculator’ (an Inclusive Design tool) 
produced by the University of Cambridge Engineering 
Design Centre uses a large database of British users with 
a range of disabilities to estimate the proportion of the 
British population (Great Britain) that is unable to use 
a product or service because of the demands that it 
places on the users’ capability.34 A version of this calcu-
lator is freely available on the Inclusive Design Toolkit 
website.34 By inputting the estimated demands of each 
task along the COPD care journey, the ‘Exclusion Calcu-
lator’ can estimate the number of people within general 
population excluded from accessing PR (in every task 
and on the whole care journey). Figure 8 shows an 
Figure 5 Example for care journey represented in a hierarchical task analysis, not all tasks and sub tasks are shown for 
clarity. COPD, chronic obstructive pulmonary disease; GP, general practitioner.
Figure 6 The standard of measuring hearing (left), reaching forward and up (middle) and speech comprehension 
(right). Examples of assessing hearing, reach and speech comprehension demand scales are shown.
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example of measuring the hearing exclusion for the 
task ‘make a telephone call’.
The original population data (sample size n=7618) is 
from the Disability Follow-up to the Family Resources 
Survey.31 Among these participants, there were nearly 
1000 participants who self-reported that they have a 
respiratory issue, and it is likely that a significant number 
of these people could benefit from PR. Although the 
exclusion numbers from the calculator are based on the 
general population (rather than those with COPD), we 
can still obtain insights about challenges raised by the 
COPD care journeys from the exclusion levels predicted. 
For some tasks, the calculator will overestimate the level 
of exclusion but still give useful insights as a loss in capa-
bility may not be due to COPD. Nonetheless, changes 
in the demand of PR on the patients with COPD will 
be reflected by changes in exploration from the whole 
population.
Output: the patient care journey map, enhanced by the 
types and levels of exclusion, will be used to evidence 
the relationship between people’s capabilities and their 
ability to access PR in step 3.
Step 3: identify challenges
Understand the most challenging part of PR and analyse 
the relationship between people’s capabilities and their 
access to PR services. The interviews, rated demand and 
the excluded number of people will provide clues to iden-
tify the most challenging issues linked to PR and develop 
initial recommendations. It will also help to analyse the 
relationships between people’s capabilities and their 
potential to access PR.
Data analysis: an inductive Framework Analysis35 will 
be used to structure the data analysis (including inter-
view transcript and exclusion data). First, initial cate-
gories/themes will be identified and put in the coding 
matrix; then, the relationship among the different 
coded data will be analysed. Finally, the core catego-
ries to propose the initial recommendations will be 
established.
Figure 7 Demand on capability of making a phone call.
Figure 8 Calculating exclusion (ie, the hearing exclusion for the task ‘make a telephone call’).
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Output: the initial recommendations that helps identify 
patients’ needs will be proposed, which contains a set of 
questions that prompts patients to consider their poten-
tial needs along their COPD care journey, in particular 
those needs that are caused by reduced capabilities when 
trying to access PR. The initial recommendations will be 
refined in step 4.
STEP 4: propose recommendation(s)
Propose and refine recommendations that aims to help 
patients understand their needs and manage their COPD 
care. These recommendations could be used as an inter-
active tool between HCPs and patients to help HCPs to 
better understand patients’ needs, especially the capa-
bility demand within the process of PR. (1) Further 
interviews with HCPs (including GPs, practice nurses or 
physiotherapists) will be conducted to obtain the views 
of HCPs on the proposed recommendations. Potential 
participants (new or existing interviewees) will be invited 
to participate by email or via a phone call. (2) Two focus 
groups will be organised that include both patients with 
COPD and HCPs to obtain the views of patients and HCPs 
on the proposed recommendations. (3) The recommen-
dations will be further refined based on the data from the 
interviews and focus groups.
Data analysis: the interview and focus group data will be 
transcribed and coded in an inductive coding structure to 
help refine the recommendations.
Output: the data analysis from the interviews and focus 
groups will help to better understand the needs of patients 
with COPD accessing PR. The refined recommendations 
that contains the key points of the COPD care journey will 
be available to inform the delivery of the PR service.
study setting
Interviews with HCPs will take place at their place of work 
or other NHS premises by arrangement.
Interviews with patients will take place on commu-
nity premises where PR classes are conducted, where 
Breathe Easy group meetings are held or at a location of 
choice (ie, the Engineering Department of University of 
Cambridge or their home with someone accompanying 
the researcher or in a coffee shop). Interviews that 
are conducted in a PR setting will be on a one-to-one 
basis to minimise any bias or any external influence. 
Overall, the researchers will need to be pragmatic about 
the timing, location and other environmental factors; 
however, the analysts will formally reflect on the influ-
ence of contextual factors on the interpretation of the 
results.
sampling and recruitment
Sampling sites
Sampling will be carried out in a single region, the EoE in 
the UK, that covers both urban and rural areas. The sites 
available to the researchers will be limited; however, 
sites in both urban and rural setting will be included to 
encourage a broad selection of professionals and patients 
to enrol in the study.
Eligibility criteria
 ► HCPs who can refer to PR programmes from 
their primary care annual review, physiotherapists 
who provide PR, PR service managers and the 
CCG strategy managers in Cambridgeshire and 
Peterborough.
 ► People resident in the EoE, aged 18 years or over, 
with a diagnosis of COPD, free from exacerbation or 
hospitalisation within the preceding 4 weeks, eligible 
for PR as defined by the guideline recommendations 
and able to read/write in English.
Size of sample
Warren36 suggested that the minimum number of inter-
views needs to be between twenty and thirty for an inter-
view-based qualitative study to be published.37 Mason 
reported that the interview number range was 1–95 (with 
a mean of 31 and a median of 28) for interview-based 
qualitative studies in doctoral theses.38 Adler also advised 
the best number of people for a qualitative research is 
between 12 and 60, with 30 being the mean.39 The size of 
sample in this study will be consistent with these recom-
mendations, and the details are shown in table 1. The 
size of the subgroups will be adjusted as necessary to 
reach data saturation to ensure the validity of the results. 
This approach complements the sampling techniques as 
described below.
Table 1 The size of sample
Category Healthcare professionals (HCPs) Patients with COPD Total
Mapping pathway:
semistructured interview
6 HCPs (including GPs, practice 
nurses or physiotherapists) and 
1–2 service managers and 1–2 
commissioners (face-to-face or by 
telephone)
11–17 patients with COPD including 
those accepted an PR offer, declined 
an PR offer and never referred (face-
to-face or by telephone)
18–25
Validation:
interviews
2–4 HCPs (face-to-face interview) and 
5–10 HCPs (email to seek comments) 
Not applicable 2–4 (interviews)
5–10 (emails)
Validation:
focus groups
1 physiotherapist×2 groups who attend 
the Breathe Easy Support group
8–10 patients×2 groups who attend the 
Breathe Easy Support group
10–24
(focus groups)
COPD, chronic obstructive pulmonary disease; PR, pulmonary rehabilitation.
8 Liu Y, et al. BMJ Open 2018;8:e020750. doi:10.1136/bmjopen-2017-020750
Open Access 
Sampling technique
Data saturation refers to a process of data collection 
whereby no substantial new insight data are generated. 
This sampling strategy will be used to gather data in 
Cambridgeshire and Peterborough. Sampling will be 
informed by the interview results to represent a range 
of care pathways/journeys and their experiences along 
the care pathways/journeys. A stakeholder map will be 
used to help identify a representative sample and gather 
adequate data. The researcher will seek advice from 
the interviewees to ensure all the key stakeholders are 
covered. If any role within the stakeholder map is missing 
or affects the data analysis, the researcher will try to find 
appropriate interviewees. The detailed plan is shown 
in table 2 and table 3 (where n refers to the number of 
people):
Sampling identification
Access methods have been discussed with Clinical 
Research Network (CRN) Eastern.
HCPs will be identified by:
i. Working with CRN Eastern locality managers to ac-
cess HCPs.
ii. Accessing HCPs through visiting or emailing GP 
practices.
iii. Accessing PR providers through EoE PR network.
In terms of identifying patients with COPD:
i. People who have accepted a PR offer will be identi-
fied through PR provider registers.
ii. People who declined a PR offer may be challenging 
to engage. HCPs and PR providers will be asked to 
identify people they know, and we will work with the 
British Lung Foundation to engage this group, for 
example, through telephone interviews/home vis-
its, or interviews while people are visiting their prac-
tice for an annual review.
iii. People who have never been referred to PR will be 
identified through COPD registers in participating 
GP practices. We will sample one GP practice in a 
city centre and another in a rural area.
Patient and Public Involvement (PPI)
The aim of our PPI activities is to ensure that we bring 
patients, accompanying carers and HCPs together to 
deliver the research collaboratively so that it compre-
hensively addresses patient needs. Patients’ enthusiasm 
has been encouraged, and we welcome their continuing 
contribution.
Five patients with COPD have contributed to the 
research questions, aim, participant sheets, interview 
schedule, consent forms and the plain English summary. 
Several discussions were held with three physiotherapists 
who provided clinicians’ perspectives on the research 
questions, aim, participant sheets, interview schedule and 
consent forms for HCPs. The lay summary and interview 
materials (participant information sheets) were reviewed 
by nine members of the PPI panel, Cambridge Univer-
sity Hospitals. They have confirmed the language used is 
understandable and have provided useful comments to 
refine the research.
The study results will be disseminated to study partici-
pants by post or email based on their preferences.
research bias
The interviews and focus groups will be used to gain 
multiple perspectives on the understanding of HCPs’ 
and patients’ experiences. The research has been care-
fully designed and has been reviewed by experts to ensure 
it will inform us of the current challenges that patients 
experience when accessing PR. The research protocol 
has been reviewed by the Research Advisory Committee 
of Cambridge University Hospitals, and advice has been 
received from the members of the PPI panel, Cambridge 
University Hospital (NHS Foundation Trust).
To reduce the risk of bias during data analysis, the 
work will be supervised by a senior researcher. A second 
researcher will independently analyse the data at each 
stage of the analysis. The primary and secondary analysts 
will compare results and resolve any discrepancies. Should 
any discrepancies not be resolved, the supervising senior 
researcher shall adjudicate.
Table 2 Recruitment plan for healthcare professionals
Healthcare 
professionals’ role Understanding of PR pathway
GPs/practice nurses 
(n=6)
Familiar with the process of diagnosis, 
annual review and referral
Physiotherapists 
(n=4–6)
Familiar with the process of referral, 
assessment for PR, PR programme 
and annual review
PR service manager 
(n=1–2)
Familiar with the whole PR pathway 
process and having connections with 
other professionals
Commissioners and 
manager (n=1–2)
Familiar with the process of designing 
or supporting the COPD care pathway
COPD, chronic obstructive pulmonary disease; PR, pulmonary 
rehabilitation.
Table 3 Recruitment plan for patients
PR 
programme
Age 
group (years) Capability
People with 
COPD
Accepted PR 
offer (n=5–7)
Declined PR 
offer (n=3–5)
Never referred 
(n=3–5)
16–49
50–64
65–74 (n≥5)
75+ (n≥2)
Hearing, vision, 
mobility, dexterity, 
reach and stretch, 
communication, 
thinking.
Ensure a full range 
of capability loss 
is covered by the 
samples
PR, pulmonary rehabilitation.
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dIsCussIon
In this protocol, we describe a novel approach to service 
improvement that takes a structured and rigorous stance 
towards analysing barriers to PR referral and uptake. An 
Inclusive Design approach has been widely used to under-
stand customer diversity and respond to this diversity with 
informed design decisions.40 The Inclusive Design methods 
used in this study have been adapted from their original 
context (measuring the exclusion of consumer products) 
and applied to care journey analysis. Specifically, one of the 
Inclusive Design tools, Exclusion Calculator, estimates the 
proportion of the British population who would be unable 
to use a product or service because of the demands that it 
places on the users’ capabilities. The tool has been widely 
used in measuring the exclusion of consumer products. 
For healthcare setting, similar to products setting, it is also 
important to understand healthcare services' demands on 
users' capabilities, so that healthcare services can be better 
developed and benefit more people, that is, more inclusive. 
A strength of the approach is that it has both qualitative 
and quantitative perspectives that give insight into how and 
where changes can be made and what impact the changes 
might have on the uptake of PR. As the Exclusion Calcu-
lator data is sampled based on general British population 
rather than people with COPD, the exclusion levels may be 
overestimated, but it can still give clues and insights about 
the needs of people with COPD. How using general popula-
tion data affects the results will be subtle, depending on the 
specific tasks where the greatest exclusion occurs and the 
capabilities needed to perform those tasks. The analysis will 
need to apply some care in interpreting the details of the 
exclusion results.
We focus on the primary care journey for people with 
COPD. We recognise that referrals for PR stem from a 
multiplicity of sources (eg, at exacerbation, by community 
specialist teams, through secondary care). However, the 
learning applied to one specific route, for example, from 
an annual review, is likely to identify at least some of the 
capability issues arising in other routes. This protocol is 
part of a first study into the application of Inclusive Design 
to healthcare processes. The authors have published one 
research that explores the role of Inclusive Design in 
improving people’s access to back pain treatment.41 The 
protocol can be adapted and applied to other PR path-
ways and indeed pathways for other conditions.
In this study, we enquire about people’s self-reported 
capabilities, rather than test them in practice to deter-
mine capabilities. This methodology of seeking self-re-
ported capabilities is validated42 and more feasible than 
extensive field testing.
The protocol focuses on physical and cognitive factors 
that contribute to preventing people from accessing PR 
services. We recognise that factors such as mental health, 
social exclusion and other factors may also affect the 
uptake of PR. Hence, this protocol is only a partial answer 
to identifying PR service exclusions. However, as previ-
ously stated, it is a prerequisite for accessing a healthcare 
service in which the service demands made do not exceed 
the capability of patients.
EthICs And dIssEMInAtIon
Assessment and management of risk
Participants may be vulnerable due to age/frailty. In 
order to manage this risk, they will be identified via GP 
practices or PR services to whom they are known and who 
can ensure participants are aware of their diagnosis of 
COPD prior to the researcher approaching them. Sources 
of support will be identified to whom participants can be 
directed.
If there is a concern about a person’s health or safety, 
the researcher may contact the relevant GP; however, as 
this would mean breaking confidentiality, it would only 
be done if the person were clearly at risk. When making 
appointments for patients to attend research activities, 
researchers will ensure that the time and location are 
acceptable to the participant.
It is recognised that interviews may involve discussion 
of sensitive topics regarding the patients’ health, lifestyle 
or quality of life. To address this:
 ► All study materials, including interview questions, have 
been developed in collaboration with a PPI group to 
ensure topics are addressed in a sensitive way.
 ► Participants will be directed to sources of support and 
information.
data protection and patient confidentiality
The Patient Information Sheet will detail the data to be 
collected and how it will be stored.
The study will comply with the Data Protection Act, 
which requires data to be anonymised as soon as it is prac-
tical to do so. The study staff will ensure that participants’ 
anonymity is maintained. Staff seeking consent will ask 
patients only for personal data that confirms their eligi-
bility for the study and at no point will study staff have 
access to patients’ medical records.
On entering the study, participants will be assigned 
an ID. Participant names will only be identifiable on 
a cross-referenced list of IDs and names, which will be 
stored in a locked filing cabinet on Trust premises. When 
recordings of interviews or focus groups are transcribed, 
only the ID will be used as an identifier.
Data collected will be entered onto secure computers in 
the Engineering Design Centre (EDC) at the University of 
Cambridge and will only be accessible to the study team. 
Paper documents will be stored in a locked cupboard in 
the EDC and will only be accessible to the study team.
All electronic files will be password protected and access 
restricted to the study team. Participants will be identified 
only by a participant ID number on any electronic data-
base. The name and any other identifying details will not 
be included in any study data electronic file. Data sharing 
and storage will meet the requirements of the National 
Institutes of Health Research. Data will be securely stored 
in the University of Cambridge Research Repository.
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Open Access 
Ethical approval
This research has been ethically reviewed and approved 
by Cambridge Central Research Ethics Committee. The 
study’s REC reference number is 17/EE/0136. It has two 
work packages: work package 1, which uses an Inclusive 
Design approach is presented above, and work package 2 
is to develop a toolkit to increase referral to and uptake 
of PR in primary care.
dissemination
We will work closely with the British Lung Foundation, 
who have a track record of disseminating innovation 
through patient networks, publications, online infor-
mation, service development and HCP engagement. 
Two academic papers will be published in peer-reviewed 
journals compliant with policy on open access on: (1) 
capabilities of patients with COPD and (2) comparison 
of COPD care pathways between HCPs and patients with 
COPD. Presentations will be given at regional, national 
and international academic and professional confer-
ences, for example East Anglian Thoracic Society, British 
Thoracic Society and European Respiratory Society. The 
output will also comprise a part of a doctoral thesis by 
the lead author. The study started in June 2017 and will 
continue until April 2018.
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